when do compounding pharmacies have to stop making semaglutide π¨ FDA Moves Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA alerts health care providers,
Description
While both are potent medications, they work in slightly different ways

Lancet Diabetes Endocrinol 6(5):361369

The supply, however, has improved, Reid says, and private companies like Ro have been improving access to the treatments
Accelerated schedules exist but carry higher side-effect risk

1:24-cv-01503-TWP-KMB (S.D
